Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Karuna Therapeutics Inc (KRTX)

Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Karuna Therapeutics Reports First Quarter 2023 Financial Results and Provides General Business Updates Business Wire - Thu May 4, 2023

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions,...

KRTX : 329.83 (+0.03%)
Karuna Therapeutics to Present at Upcoming Investor Conferences Business Wire - Tue May 2, 2023

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions,...

KRTX : 329.83 (+0.03%)
3 Biotech Buyout Targets to Watch Motley Fool - Sat Apr 29, 2023

The trio all have late-stage therapies with blockbuster potential.

ETNB : 8.38 (+5.01%)
KRTX : 329.83 (+0.03%)
MORF : 56.99 (+0.04%)
PureTech Announces Annual Results for Year Ended December 31, 2022 Business Wire - Fri Apr 28, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”) today announces its results for the year ended December 31, 2022, as well as its cash balance as of the first quarter...

PRTC : 21.78 (+0.39%)
PRTC.LN : 162.000 (+0.12%)
BIIB : 158.01 (+1.29%)
KRTX : 329.83 (+0.03%)
VOR : 0.7961 (+0.16%)
AKLI : 0.4320 (-0.62%)
Karuna Therapeutics to Announce First Quarter 2023 Financial Results and Provide General Business Update on Thursday, May 4, 2023 Business Wire - Thu Apr 20, 2023

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions,...

KRTX : 329.83 (+0.03%)
Karuna Therapeutics Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares Business Wire - Fri Mar 24, 2023

Karuna Therapeutics, Inc. (NASDAQ: KRTX) (“Karuna”), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological...

KRTX : 329.83 (+0.03%)
Karuna Therapeutics to Present at the Stifel 2023 CNS Days Business Wire - Thu Mar 23, 2023

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions,...

KRTX : 329.83 (+0.03%)
Why Shares of Karuna Therapeutics Were Up Wednesday Motley Fool - Wed Mar 22, 2023

The clinical-stage biotech announced positive trial results for its lead therapy.

KRTX : 329.83 (+0.03%)
Karuna Therapeutics Announces Pricing of Public Offering of Common Stock Business Wire - Tue Mar 21, 2023

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions,...

KRTX : 329.83 (+0.03%)
Karuna Therapeutics Announces Proposed Public Offering of Common Stock Business Wire - Mon Mar 20, 2023

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions,...

KRTX : 329.83 (+0.03%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth Barchart - Thu Nov 21, 7:18PM CST
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot